Put Options

8 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

SELL
N/A
-13,900 Reduced 49.64%
14,100 $0
Q2 2024

Aug 15, 2024

SELL
N/A
-38,100 Reduced 57.64%
28,000 $0
Q1 2024

May 07, 2024

SELL
N/A
-6,000 Reduced 8.32%
66,100 $0
Q4 2023

Feb 14, 2024

SELL
N/A
-90,200 Reduced 55.58%
72,100 $0
Q3 2023

Nov 14, 2023

SELL
N/A
-17,500 Reduced 9.73%
162,300 $0
Q2 2023

Aug 11, 2023

BUY
N/A
159,900 Added 803.52%
179,800 $0
Q1 2023

May 16, 2023

SELL
N/A
-8,100 Reduced 28.93%
19,900 $0
Q4 2022

Feb 14, 2023

BUY
$0.0 - $9.95 $0 - $278,600
28,000 New
28,000 $0

Others Institutions Holding LNDC

About LANDEC CORP \CA\


  • Ticker LNDC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 29,595,600
  • Description
  • Landec Corporation operates as a diversified health and wellness company. The company manufactures pharmaceutical-grade sodium hyaluronate (HA)-based biomaterials for primary use in the ophthalmic and orthopedic markets. It also provides product development services to its partners for HA-based, as well as non-HA based, aseptically formulated, a...
More about LNDC
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.